Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study Providing 12 Months of Safety Follow-Up From First Exposure to HP802-247 in Subjects Who Participated in Study 802-247-09-032(EU)

NCT01970657 is registered in ClinicalTrials.gov with Healthpoint as lead sponsor.

NCT NCT01970657
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01970657 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study Providing 12 Months of Safety Follow-Up From First Exposure to HP802-247 in Subjects Who Participated in Study 802-247-09-032(EU)
Lead sponsor
Healthpoint
Phase
Observational
Overall status
Completed
Start date
May 31, 2014
Completion date
November 30, 2015
Enrollment
221 (actual)
Sites
43

Conditions

As the registry lists them; a condition with its own page is linked.

venous leg ulcer (vlu)